Robin Arora in South Point, Ohio

Additional Medical Specialties Include:
NEPHROLOGY, ADDICTION MEDICINE, INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2002
The Primary Medical Specialty for Robin Arora is listed as: Internal Medicine
Approximate Years of Experience: 22
PAC (PECOS ID)#: 0042403297
NPI #: 1144481565
NPI Created On: 06/18/2008
NPI Last Updated Listed as: 01/03/2024
Primary Taxonomy Code: 207RN0300X
License Number:
35.095400
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Blue Cross Blue Shield
• Humana
• CareSource
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Hindi, English, Punjabi.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Testing for presence of drug
3. Hemodialysis procedure with one physician evaluation
4. Dialysis services (4 or more physician visits per month), patient 20 years of age and older
5. Dialysis services (2-3 physician visits per month), patient 20 years of age and older
6. Dialysis services (1 physician visit per month), patient 20 years of age and older
7. New patient office or other outpatient visit, typically 20 minutes
8. New patient office or other outpatient visit, typically 45 minutes
9. Established patient office or other outpatient visit, typically 5 minutes
10. Established patient office or other outpatient visit, typically 10 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Initial hospital inpatient care, typically 50 minutes per day
14. Initial hospital inpatient care, typically 70 minutes per day
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Subsequent hospital inpatient care, typically 35 minutes per day
17. Hospital discharge day management, more than 30 minutes
18. Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
19. Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
20. Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms